Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 403
Selected: 0
NCT IDTitle
NCT00096239CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
NCT00301990Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
NCT00234000Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
NCT00093704Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma
NCT02775292Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1
NCT00020800Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia
NCT05720988Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid Leukemia
NCT02816879Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men
NCT06995053Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial
NCT00346372Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
NCT01591577Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme
NCT02902757FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma
NCT04399824Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer
NCT00022685Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma
NCT04282824Impact of Monosodium Glutamate on 68GA-PSMA-11, PET Imaging Biodistribution in Patients With Prostate Cancer
NCT00005083Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
NCT00070382Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
NCT0217467968Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)
NCT01525264Breast Cancer Screening Intervention
NCT00003748Irinotecan in Treating Patients With Esophageal or Stomach Cancer
NCT00335868PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy
NCT05000359A Mobile Phone Intervention to Promote Adherence to Survivorship Care Among Adolescent and Young Adult Cancer Survivors
NCT01536743A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression
NCT06090643Implementation Research to Increase Colorectal Cancer Screening Rates Among Low Income and Ethnic Minority Groups
NCT07276438Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial
NCT00004114Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer
NCT07293585Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment
NCT02092948Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer
NCT02830165Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery
NCT03603223Pembrolizumab in Treating Participants With Leukoplakia
NCT06090903Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
NCT07716735Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer
NCT03672773Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer
NCT00022386Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer
NCT07605546RAD ONC FREEDOM Oncology Pain
NCT04765150Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
NCT04290897Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors
NCT06543576External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer
NCT04280471Fecal Microbiota Transplantation for the Treatment of Severe Acute Gut Graft-Versus-Host Disease
NCT04297020Brain Health in Breast Cancer Survivors
NCT02597894Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy
NCT00079222Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
NCT00098462Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT02866994Project Connect Online: An Internet-based Intervention for Women With Breast Cancer
NCT02701153Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
NCT00998010Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
NCT00081068Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia
NCT00045318Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction
NCT04915508Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy
NCT00021008ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer